🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Voluntary HIV Screening in the General Population in France

Recruitingn/aAges 18 Years - anyAllUniversité de Reims Champagne-Ardenne
NCT07418385 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 18 years of age or older * Male or female * Regardless of sexual orientation * Whether or not they have previously undergone voluntary HIV testing * Agreeing to participate in the study. Exclusion Criteria: * Minors * Refusing to participate in the study
💊

What it tests

  • data collections
📍

Where

1 site
Ufr Medecine Urca
Reims, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy